サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：オンライン薬局 (ePharmacy) 市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
市場調査レポート
商品コード
1166011

オンライン薬局 (ePharmacy) 市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

ePharmacy Market (Product: Prescription Medicines, Over-the-counter Products, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 156 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
オンライン薬局 (ePharmacy) 市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年10月03日
発行: Transparency Market Research
ページ情報: 英文 156 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のオンライン薬局市場について調査し、市場の概要とともに、2022年～2031年の予測、製品別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー：世界のオンライン薬局市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界のオンライン薬局市場の分析と予測、2017年～2031年

第5章 主な洞察

第6章 世界のオンライン薬局市場分析と予測、製品別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 製品別の市場価値予測、2017年～2031年
    • 処方薬
    • OTC薬
    • その他（診断サービス）
  • 製品別の市場魅力分析

第7章 世界のオンライン薬局市場分析と予測、地域別

  • 主な調査結果
  • 地域別市場価値予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場魅力分析

第8章 北米のオンライン薬局市場の分析と予測

第9章 欧州のオンライン薬局市場の分析と予測

第10章 アジア太平洋のオンライン薬局市場の分析と予測

第11章 ラテンアメリカのオンライン薬局市場の分析と予測

第12章 中東・アフリカのオンライン薬局市場分析と予測

第13章 競合情勢

  • 市場参入企業 -競合マトリクス
  • 市場シェア分析、企業別（2021年）
  • 企業プロファイル
    • Chemist Direct
    • DocMorris
    • Express Scripts Holding Company
    • Giant Eagle, Inc.
    • Healthxchange Pharmacy
    • LloydsPharmacy
    • MedExpress
    • Netmeds
    • Optum Rx, Inc.
    • Phar中東・アフリカsy
    • 1Mg
    • Rowlands Pharmacy
    • The Kroger Co.
    • Walgreen Co.
    • Well Pharmacy
図表

List of Tables

  • Table 01: Global ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global ePharmacy Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 03: North America ePharmacy Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 04: North America ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 05: Europe ePharmacy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 06: Europe ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 07: Asia Pacific ePharmacy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Asia Pacific ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 09: Latin America ePharmacy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Latin America ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 11: Middle East & Africa ePharmacy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Middle East & Africa ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017-2031

List of Figures

  • Figure 01: Global ePharmacy Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031
  • Figure 02: Global ePharmacy Market Revenue (US$ Mn), by Product, 2021
  • Figure 03: Global ePharmacy Market Value Share, by Product, 2021
  • Figure 04: Global ePharmacy Market Value Share, by Region, 2021
  • Figure 05: Global ePharmacy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 06: Global ePharmacy Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 07: Global ePharmacy Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 08: Global ePharmacy Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 09: North America ePharmacy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 10: North America ePharmacy Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 11: North America ePharmacy Market Value Share Analysis, by Country, 2017 and 2031
  • Figure 12: North America ePharmacy Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 13: North America ePharmacy Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 14: Europe ePharmacy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 15: Europe ePharmacy Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 16: Europe ePharmacy Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 17: Europe ePharmacy Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 18: Europe ePharmacy Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 19: Asia Pacific ePharmacy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 20: Asia Pacific ePharmacy Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 21: Asia Pacific ePharmacy Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 22: Asia Pacific ePharmacy Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 23: Asia Pacific ePharmacy Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 24: Latin America ePharmacy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 25: Latin America ePharmacy Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 26: Latin America ePharmacy Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 27: Latin America ePharmacy Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 28: Latin America ePharmacy Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 29: Middle East & Africa ePharmacy Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 30: Middle East & Africa ePharmacy Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 31: Middle East & Africa ePharmacy Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 32: Middle East & Africa ePharmacy Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 33: Middle East & Africa ePharmacy Market Attractiveness Analysis, by Product, 2022-2031
目次
Product Code: TMRGL397

TMR's report on the global ePharmacy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global ePharmacy market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ePharmacy market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ePharmacy market.

The report delves into the competitive landscape of the global ePharmacy market. Key players operating in the global ePharmacy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global ePharmacy market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global ePharmacy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global ePharmacy Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pricing Analysis
  • 5.2. Key Industry Events (mergers, acquisitions, collaborations, approvals, etc.)
  • 5.3. COVID-19 Impact Analysis
  • 5.4. Regulatory Scenario

6. Global ePharmacy Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Prescription Medicine
    • 6.3.2. Over-the-counter (OTC) Products
    • 6.3.3. Other (Diagnostic Services)
  • 6.4. Market Attractiveness Analysis, by Product

7. Global ePharmacy Market Analysis and Forecast, by Region

  • 7.1. Key Findings
  • 7.2. Market Value Forecast, by Region
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. Market Attractiveness Analysis, by Region

8. North America ePharmacy Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
  • 8.2. Market Value Forecast, by Product, 2017-2031
    • 8.2.1. Prescription Medicine
    • 8.2.2. Over-the-counter (OTC) Products
    • 8.2.3. Other
  • 8.3. Market Value Forecast, by Country, 2017-2031
    • 8.3.1. U.S.
    • 8.3.2. Canada
  • 8.4. Market Attractiveness Analysis
    • 8.4.1. By Product
    • 8.4.2. By Country

9. Europe ePharmacy Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product, 2017-2031
    • 9.2.1. Prescription Medicine
    • 9.2.2. Over-the-counter (OTC) Products
    • 9.2.3. Other
  • 9.3. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 9.3.1. Germany
    • 9.3.2. U.K.
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Market Attractiveness Analysis
    • 9.4.1. By Product
    • 9.4.2. By Country/Sub-region

10. Asia Pacific ePharmacy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Prescription Medicine
    • 10.2.2. Over-the-counter (OTC) Products
    • 10.2.3. Other
  • 10.3. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia & New Zealand
    • 10.3.5. Rest of Asia Pacific
  • 10.4. Market Attractiveness Analysis
    • 10.4.1. By Product
    • 10.4.2. By Country/Sub-region

11. Latin America ePharmacy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Prescription Medicine
    • 11.2.2. Over-the-counter (OTC) Products
    • 11.2.3. Other
  • 11.3. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Product
    • 11.4.2. By Country/Sub-region

12. Middle East & Africa ePharmacy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Prescription Medicine
    • 12.2.2. Over-the-counter (OTC) Products
    • 12.2.3. Other
  • 12.3. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Rest of Middle East & Africa
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Product
    • 12.4.2. By Country/Sub-region

13. Competition Landscape

  • 13.1. Market Player - Competitive Matrix (by tier and size of companies
  • 13.2. Market Share Analysis, by Company (2021)
  • 13.3. Company Profiles
    • 13.3.1. Chemist Direct
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio
      • 13.3.1.3. SWOT Analysis
      • 13.3.1.4. Financial Overview
      • 13.3.1.5. Strategic Overview
    • 13.3.2. DocMorris
      • 13.3.2.1. Company Overview
      • 13.3.2.2. Product Portfolio
      • 13.3.2.3. SWOT Analysis
      • 13.3.2.4. Financial Overview
      • 13.3.2.5. Strategic Overview
    • 13.3.3. Express Scripts Holding Company
      • 13.3.3.1. Company Overview
      • 13.3.3.2. Product Portfolio
      • 13.3.3.3. SWOT Analysis
      • 13.3.3.4. Financial Overview
      • 13.3.3.5. Strategic Overview
    • 13.3.4. Giant Eagle, Inc.
      • 13.3.4.1. Company Overview
      • 13.3.4.2. Product Portfolio
      • 13.3.4.3. SWOT Analysis
      • 13.3.4.4. Financial Overview
      • 13.3.4.5. Strategic Overview
    • 13.3.5. Healthxchange Pharmacy
      • 13.3.5.1. Company Overview
      • 13.3.5.2. Product Portfolio
      • 13.3.5.3. SWOT Analysis
      • 13.3.5.4. Financial Overview
      • 13.3.5.5. Strategic Overview
    • 13.3.6. LloydsPharmacy
      • 13.3.6.1. Company Overview
      • 13.3.6.2. Product Portfolio
      • 13.3.6.3. SWOT Analysis
      • 13.3.6.4. Financial Overview
      • 13.3.6.5. Strategic Overview
    • 13.3.7. MedExpress
      • 13.3.7.1. Company Overview
      • 13.3.7.2. Product Portfolio
      • 13.3.7.3. SWOT Analysis
      • 13.3.7.4. Financial Overview
      • 13.3.7.5. Strategic Overview
    • 13.3.8. Netmeds
      • 13.3.8.1. Company Overview
      • 13.3.8.2. Product Portfolio
      • 13.3.8.3. SWOT Analysis
      • 13.3.8.4. Financial Overview
      • 13.3.8.5. Strategic Overview
    • 13.3.9. Optum Rx, Inc.
      • 13.3.9.1. Company Overview
      • 13.3.9.2. Product Portfolio
      • 13.3.9.3. SWOT Analysis
      • 13.3.9.4. Financial Overview
      • 13.3.9.5. Strategic Overview
    • 13.3.10. PharmEasy
      • 13.3.10.1. Company Overview
      • 13.3.10.2. Product Portfolio
      • 13.3.10.3. SWOT Analysis
      • 13.3.10.4. Financial Overview
      • 13.3.10.5. Strategic Overview
    • 13.3.11. 1Mg
      • 13.3.11.1. Company Overview
      • 13.3.11.2. Product Portfolio
      • 13.3.11.3. SWOT Analysis
      • 13.3.11.4. Financial Overview
      • 13.3.11.5. Strategic Overview
    • 13.3.12. Rowlands Pharmacy
      • 13.3.12.1. Company Overview
      • 13.3.12.2. Product Portfolio
      • 13.3.12.3. SWOT Analysis
      • 13.3.12.4. Financial Overview
      • 13.3.12.5. Strategic Overview
    • 13.3.13. The Kroger Co.
      • 13.3.13.1. Company Overview
      • 13.3.13.2. Product Portfolio
      • 13.3.13.3. SWOT Analysis
      • 13.3.13.4. Financial Overview
      • 13.3.13.5. Strategic Overview
    • 13.3.14. Walgreen Co.
      • 13.3.14.1. Company Overview
      • 13.3.14.2. Product Portfolio
      • 13.3.14.3. SWOT Analysis
      • 13.3.14.4. Financial Overview
      • 13.3.14.5. Strategic Overview
    • 13.3.15. Well Pharmacy
      • 13.3.15.1. Company Overview
      • 13.3.15.2. Product Portfolio
      • 13.3.15.3. SWOT Analysis
      • 13.3.15.4. Financial Overview
      • 13.3.15.5. Strategic Overview